Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nikolaus Marx

Showing results (41-50 of 566) with videos related to

Pageof 57
Sort By:
Current Cardiology Reports|February 3, 2026
Combination Lipid-Lowering Therapy After ACS: Should this be the New Standard of Care?Julia Brandts, Nikolaus Marx
Current Atherosclerosis Reports|June 7, 2013
C-Peptide and its career from innocent bystander to active player in diabetic atherogenesisCorinna Lebherz, Nikolaus Marx
Deutsche Medizinische Wochenschrift (1946)|October 11, 2017
[Not Available]Sebastian Reith, Nikolaus Marx
Seminars in Immunopathology|April 7, 2009
Advanced glycation end products and C-peptide-modulators in diabetic vasculopathy and atherogenesisDaniel Walcher, Nikolaus Marx
Deutsches Arzteblatt International|January 4, 2019
Oral AnticoagulationErtunc Altiok, Nikolaus Marx
The American Journal of Cardiology|June 14, 2017
Diabetes Mellitus and Heart FailureMichael Lehrke, Nikolaus Marx
Current Opinion in Lipidology|October 17, 2012
New antidiabetic therapies: innovative strategies for an old problemMichael Lehrke, Nikolaus Marx
Deutsches Arzteblatt International|May 9, 2019
In ReplyErtunc Altiok, Nikolaus Marx
Diabetes Care|September 10, 2020
Prescribing Paradigm Shift? Damned If You Do, Damned If You Don'tNikolaus Marx, Peter J Grant
Deutsche Medizinische Wochenschrift (1946)|April 30, 2020
[Therapy of type 2 diabetes - Recommendations of the European Association for the Study of Diabetes (EASD)]Dirk Müller-Wieland, Nikolaus Marx
Pageof 57

Showing results (41-50 of 566) with videos related to

Sort By:
Pageof 57
Current Cardiology Reports|February 3, 2026
Combination Lipid-Lowering Therapy After ACS: Should this be the New Standard of Care?Julia Brandts, Nikolaus Marx
Current Atherosclerosis Reports|June 7, 2013
C-Peptide and its career from innocent bystander to active player in diabetic atherogenesisCorinna Lebherz, Nikolaus Marx
Deutsche Medizinische Wochenschrift (1946)|October 11, 2017
[Not Available]Sebastian Reith, Nikolaus Marx
Seminars in Immunopathology|April 7, 2009
Advanced glycation end products and C-peptide-modulators in diabetic vasculopathy and atherogenesisDaniel Walcher, Nikolaus Marx
Deutsches Arzteblatt International|January 4, 2019
Oral AnticoagulationErtunc Altiok, Nikolaus Marx
The American Journal of Cardiology|June 14, 2017
Diabetes Mellitus and Heart FailureMichael Lehrke, Nikolaus Marx
Current Opinion in Lipidology|October 17, 2012
New antidiabetic therapies: innovative strategies for an old problemMichael Lehrke, Nikolaus Marx
Deutsches Arzteblatt International|May 9, 2019
In ReplyErtunc Altiok, Nikolaus Marx
Diabetes Care|September 10, 2020
Prescribing Paradigm Shift? Damned If You Do, Damned If You Don'tNikolaus Marx, Peter J Grant
Deutsche Medizinische Wochenschrift (1946)|April 30, 2020
[Therapy of type 2 diabetes - Recommendations of the European Association for the Study of Diabetes (EASD)]Dirk Müller-Wieland, Nikolaus Marx
Pageof 57